Earth Science Tech, Inc. (ETST) Celebrates A Year of Major Achievements and Shares its Position for a Pivotal 2019

DORAL, Florida, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, reviews the Company’s 2018 achievements and shares what’s to come in 2019.

Q1

During the fiscal first quarter, the Company expanded its executive team with the appointment of Jill Buzan as a new Chief Sales Officer (CSO) and Wendell Hecker as Chief Financial Officer (CFO). Since the first of the year, under Buzan and Hecker’s leadership, sales have increased over 100 percent. The Company has also become fully reporting, employing accurate bookkeeping throughout the process.

At the end of Q1, the Company appointed a new chief operating officer (COO), while Nickolas S. Tabraue, the COO at the time, continued as President, Director and Chairman to focus on the company’s expansion. Since the addition of Gagan Hunter as COO, the Company has increased inventory control accuracy, which has assisted in the full reporting process and made company audits easier, ultimately helping the company achieve a smooth transition as it grows. 

Q2

During the fiscal second quarter, the Company added a pharmacist & LP3 as Chief of Pharmacy, furthering efforts to obtain a license to distribute controlled substances. Since Jad Nammour joined the Company, he has assisted in the development of the Company’s CBD nutraceutical-based IPs and medical device.

Q3

During the fiscal third quarter, the Company achieved fully reporting status with the SEC under the exchange act of 1934. Since achieving fully reporting status and with the resulting increased transparency, the Company has been able to obtain more direct and retail investors.

In the middle of Q3, the Company officially uplisted to the OTCQB Exchange, operating as a OTCQB Company with fully reporting status. This status has positioned the Company to a higher standard, providing a strong baseline for transparency as well as technology and regulations that improve the flow of information and trading experience for investors. U.S. investors can find current financial disclosure and real-time level2 quotes for ETST.

At the end of Q3, the Company initiated a DRTV media campaign with former Shark Tank star Kevin Harrington’s award-winning As Seen On TV production company. Production on the campaign has begun and the Company anticipates a Q2019 launch date. The campaign being created for ETST will include:

·A 60-second DRTV commercial spot to be aired 300 times within 10 selected regions and selected networks.

·A 15-second promotional video to be used for digital and social media purposes.

·A featured placement on the website for 13 months

·Complete licensing rights to the commercial spot and promotional video, and permission to use the world famous As Seen On TV logo on ETST’s products.

Q4

During the fiscal fourth quarter, the Company’s partnership with Bionatus is almost market ready.

A major Q4 achievement was the Company’s first commercial production run of Hygee(TM) medical device kits that easily test for chlamydia. Hygeeâ„¢ anticipates strong sales growth in years two and three after product launch. As soon as year one, sales of Hygeeâ„¢ and the associated in vitro molecular diagnoses should reach between $1.5 million and $2.5 million USD. Second year sales should reach $1 million monthly and up to $20 million yearly as early as the third year. These numbers are supported by the fact that chlamydia is a global issue; that the company’s network of distributors is worldwide; and that the thin structure of the device and the stability of the specimen collected with Hygeeâ„¢ ensures that it can be easily dispersed on all continents.  

At the end of Q4, the Company engaged counsel with Canadian Securities Exchange (CSE) expertise to assist with dual listing. Listing could happen as early as in the third quarter of the Company’s current fiscal year and would require certain regulatory approvals that would allow Earth Science to market and sell its common shares to Canadian investors.

ETST Management Reviews 2018, Looks Ahead

 â€œIn 2018, we made sufficient changes to i mprove our point of sale system, inventory and accounting management systems, improved on our manufacturing and packaging, strengthened the potency and effectiveness of our products, and increased our sales I am confident with the implementation of these changes and the addition of our new CSO, David Barbash. The company will reach new heights in 2019 as we now focus on increasing and expanding our sales force and employ a new marketing team. As we increase our distribution and presence in the marketplace, 2019 will be the best year in the company's history.” - Gagan Hunter, COO & Director

• 1